Arnhold LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.2M Hold
22,952
0.23% 59
2025
Q4
$2.82M Hold
22,952
0.21% 56
2025
Q3
$2.55M Hold
22,952
0.21% 60
2025
Q2
$2.54M Hold
22,952
0.23% 58
2025
Q1
$2.57M Hold
22,952
0.26% 52
2024
Q4
$2.12M Hold
22,952
0.21% 56
2024
Q3
$1.92M Hold
22,952
0.19% 53
2024
Q2
$1.57M Hold
22,952
0.17% 57
2024
Q1
$1.68M Hold
22,952
0.18% 57
2023
Q4
$1.86M Sell
22,952
-279
-1% -$21.7K 0.21% 54
2023
Q3
$1.74M Hold
23,231
0.21% 60
2023
Q2
$1.79M Sell
23,231
-3
-0% -$239 0.2% 63
2023
Q1
$1.93M Buy
23,234
+23
+0.1% +$1.91K 0.22% 63
2022
Q4
$1.99M Hold
23,211
0.24% 63
2022
Q3
$1.43M Buy
23,211
+15
+0.1% +$946 0.19% 65
2022
Q2
$1.43M Buy
23,196
+152
+0.7% +$9.41K 0.17% 68
2022
Q1
$1.37M Buy
+23,044
New +$1.47M 0.15% 70
2020
Q1
Sell
-191,588
Closed -$12.4M 143
2019
Q4
$12.4M Buy
191,588
+19,614
+11% +$1.28M 1.97% 13
2019
Q3
$10.9M Buy
171,974
+2,017
+1% +$132K 1.85% 14
2019
Q2
$11.5M Buy
169,957
+29,028
+21% +$1.91M 2.01% 11
2019
Q1
$9.16M Buy
140,929
+16,352
+13% +$1.09M 1.65% 17
2018
Q4
$7.79M Buy
124,577
+793
+0.6% +$55.4K 1.45% 24
2018
Q3
$9.56M Buy
123,784
+884
+0.7% +$66.8K 1.65% 17
2018
Q2
$8.71M Buy
122,900
+20,000
+19% +$1.41M 1.53% 20
2018
Q1
$7.76M Buy
+102,900
New +$8.18M 1.47% 16

Other funds holding GILD

Arnhold LLC's GILD Position: Q1 2026 in Review

Arnhold LLC held its Gilead Sciences (GILD) position steady in Q1 2026 at 22,952 shares worth $3.2M. The position accounts for 0.23% of the portfolio, ranked #59.

Arnhold LLC first reported a position in GILD in Q1 2018 and has held it in 25 quarters since. The position peaked at $12.4M in Q4 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Arnhold LLC held 22,952 shares of Gilead Sciences worth $3.2M as of Q1 2026.
  • Arnhold LLC left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.23% of Arnhold LLC's portfolio in Q1 2026, its #59 holding.
  • Arnhold LLC first reported a position in Gilead Sciences in Q1 2018 and has held it in 25 quarters since.
  • Arnhold LLC's Gilead Sciences position peaked at $12.4M in Q4 2019.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Arnhold LLC's 13F filing for Q1 2026, filed 11 May 2026.